A tiny RNA with a big role in melanoma

A tiny RNA with a big role in melanoma
Credit:

A Yale-led study has identified a key mechanism in the regulation of gene expression that promotes the proliferation of melanoma cells. The finding opens a possible avenue for development of treatments that target this mechanism. The study appears online Feb. 18 in the journal eLife.

Melanoma is the deadliest form of skin cancer. BRAF and NRAS genetic mutations are known to occur in a very large proportion of melanomas. But although scientists have identified the oncogenic mutations that trigger and their proliferation, the mechanism that causes to transform into cancerous melanoma cells and cause their spread has not been well defined.

The Yale team identified a microRNA called miR-146a that accelerates in activity in the presence of these oncogenes by activating a cancer promoting signaling pathway called Notch.

The authors suggest that Notch and another signaling pathway called MAP kinase, which is activated by these same oncogenes, represent a valuable drug development target. "Our study has identified a new genetic vulnerability in melanoma, and it is likely that simultaneous inhibition of MAP Kinase pathway and NOTCH will emerge as a better therapeutic option to treat patients," said senior author Narendra Wajapeyee, assistant professor of pathology at Yale School of Medicine and a member of Yale Cancer Center.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Endogenous hormones improve breast cancer risk models

20 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

21 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments